Cochrane Abstracts
Intravenous beta 2 -agonists versus intravenous aminophylline for acute asthma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Beta 2 -agonists Versus Intravenous Aminophylline for Acute Asthma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434376/all/Intravenous_beta_2__agonists_versus_intravenous_aminophylline_for_acute_asthma:_Cochrane_systematic_review. Accessed 08 October 2024.
Intravenous beta 2 -agonists versus intravenous aminophylline for acute asthma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434376/all/Intravenous_beta_2__agonists_versus_intravenous_aminophylline_for_acute_asthma:_Cochrane_systematic_review. Accessed October 8, 2024.
Intravenous beta 2 -agonists versus intravenous aminophylline for acute asthma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434376/all/Intravenous_beta_2__agonists_versus_intravenous_aminophylline_for_acute_asthma:_Cochrane_systematic_review
Intravenous Beta 2 -agonists Versus Intravenous Aminophylline for Acute Asthma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 October 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434376/all/Intravenous_beta_2__agonists_versus_intravenous_aminophylline_for_acute_asthma:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous beta 2 -agonists versus intravenous aminophylline for acute asthma: Cochrane systematic review
ID - 434376
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434376/all/Intravenous_beta_2__agonists_versus_intravenous_aminophylline_for_acute_asthma:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
